Security Snapshot

Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) Institutional Ownership

CUSIP: 42225T107

13F Institutional Holders and Ownership History from Q3 2019 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

127

Shares (Excl. Options)

55,690,272

Price

$1.27

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+987,251
Value change
-$2,578,183
Number of holders
127
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
73,352,849
SEC-reported price per share
$1.34
Insider filing price
$1.34
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 42225T107.
  • 127 institutions reported positions in Q1 2026.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 136 to 127 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $132,053,597 to $70,644,603.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 127 institutions filings for Q1 2026.

Open SEC evidence

Security key

42225T107

Latest holder period

Q1 2026

13F holders

127

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
HCAT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
First Light Asset Management, LLC 18% -6.9% $26,796,092 -$909,928 13,465,373 -3.3% Mathew P. Arens 12 Mar 2026
Stoney Lonesome HF LP 8.6% +62% $6,686,846 +$2,554,141 6,308,345 +62% COGHILL CLINT D 31 Mar 2026
Whetstone Capital Advisors, LLC 8.2% +11% $12,491,153 +$1,117,938 5,782,941 +9.8% Whetstone Capital Advisors, LLC 17 Feb 2026
BlackRock, Inc. 6.3% $17,542,785 4,407,735 BlackRock, Inc. 31 Mar 2025

As of 31 Mar 2026, 127 institutional investors reported holding 55,690,272 shares of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT). This represents 76% of the company’s total 73,352,849 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
69%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
First Light Asset Management, LLC 18% 12,878,700 -0.25% 1.5% $16,355,949
CDC Financial, Inc. 8.6% 6,307,054 +58% 6.6% $8,009,959
BlackRock, Inc. 7% 5,138,022 -1.1% 0% $6,525,289
Whetstone Capital Advisors, LLC 5.8% 4,268,141 +14% 2% $5,420,539
Palogic Value Management, L.P. 3.9% 2,896,600 +128% 1.6% $3,678,682
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 2,885,653 0% 0% $3,664,779
Impax Asset Management Group plc 3.7% 2,750,000 0% 0.02% $3,492,500
Nepsis Inc. 2.6% 1,876,289 -2.1% 0.8% $2,382,887
GEODE CAPITAL MANAGEMENT, LLC 2% 1,501,433 -10% 0% $1,907,233
STATE STREET CORP 1.8% 1,324,849 -0.23% 0% $1,682,558
DIMENSIONAL FUND ADVISORS LP 1.7% 1,234,870 -25% 0% $1,567,789
HighMark Wealth Management LLC 1.2% 903,082 +22% 0.46% $1,134,214
Caption Management, LLC 1.1% 771,886 0.05% $980,295
Prescott Group Capital Management, L.L.C. 0.97% 710,803 +127% 0.09% $902,720
JPMORGAN CHASE & CO 0.92% 677,949 -9.9% 0% $799,980
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.83% 606,858 +11% 0% $770,710
AQR CAPITAL MANAGEMENT LLC 0.74% 543,244 +540% 0% $689,920
VANGUARD PORTFOLIO MANAGEMENT LLC 0.72% 531,014 0% 0% $674,388
MARTIN & CO INC /TN/ 0.72% 526,186 +2.5% 0.11% $668,256
KENNEDY CAPITAL MANAGEMENT LLC 0.69% 509,782 -47% 0.01% $647,423
NORTHERN TRUST CORP 0.67% 493,846 +3.7% 0% $627,184
VANGUARD FIDUCIARY TRUST CO 0.6% 443,665 0% 0% $563,455
GOLDMAN SACHS GROUP INC 0.53% 387,172 +22% 0% $491,708
Baird Financial Group, Inc. 0.5% 370,309 -25% 0% $470,292
FMR LLC 0.5% 367,473 +5.4% 0% $466,690

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
27
Latest
Q1 2026
Rows shown
1-25 of 27
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 55,690,272 $70,644,603 -$2,578,183 $1.27 127
2025 Q4 55,255,926 $132,053,597 -$6,516,575 $2.39 136
2025 Q3 54,134,724 $154,287,158 -$4,573,641 $2.85 142
2025 Q2 54,164,187 $204,239,601 +$2,031,442 $3.77 144
2025 Q1 53,179,756 $240,899,632 -$15,089,868 $4.53 163
2024 Q4 51,714,283 $365,529,299 +$10,713,924 $7.07 164
2024 Q3 52,033,442 $423,157,153 +$11,669,218 $8.14 158
2024 Q2 50,973,377 $325,694,724 +$3,633,936 $6.39 159
2024 Q1 50,065,423 $376,991,717 +$764,949 $7.53 170
2023 Q4 49,726,125 $460,463,313 +$1,604,271 $9.26 165
2023 Q3 49,374,836 $499,663,628 +$2,966,722 $10.12 155
2023 Q2 48,824,578 $610,231,678 +$4,102,989 $12.50 152
2023 Q1 48,547,295 $566,456,324 -$1,965,202 $11.67 158
2022 Q4 48,846,831 $519,237,991 -$2,727,981 $10.63 164
2022 Q3 49,010,406 $475,542,822 -$73,165,265 $9.70 163
2022 Q2 52,853,537 $766,547,805 -$46,880,972 $14.49 170
2022 Q1 53,285,286 $1,391,839,063 -$65,374,738 $26.13 180
2021 Q4 55,189,855 $2,186,203,412 +$48,206,866 $39.62 178
2021 Q3 53,304,379 $2,668,051,943 +$252,469,889 $50.01 198
2021 Q2 48,146,470 $2,673,141,898 +$252,885,500 $55.51 197
2021 Q1 43,869,916 $2,051,715,173 +$163,395,411 $46.77 187
2020 Q4 40,380,352 $1,757,762,073 +$87,929,967 $43.53 168
2020 Q3 40,018,208 $1,463,894,335 +$230,365,790 $36.60 138
2020 Q2 33,977,864 $991,115,334 +$212,900,758 $29.17 127
2020 Q1 27,081,811 $708,117,425 +$93,437,343 $26.15 107
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .